A citation-based method for searching scientific literature

Olga A Dravolina, Edwin Zvartau, Wojciech Danysz, Anton Y Bespalov. Psychopharmacology (Berl) 2017
Times Cited: 4







List of co-cited articles
5 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Chemical modulation of mutant mGlu1 receptors derived from deleterious GRM1 mutations found in schizophrenics.
Hyekyung P Cho, Pedro M Garcia-Barrantes, John T Brogan, Corey R Hopkins, Colleen M Niswender, Alice L Rodriguez, Daryl F Venable, Ryan D Morrison, Michael Bubser, J Scott Daniels,[...]. ACS Chem Biol 2014
35
50

Prospects for metabotropic glutamate 1 receptor antagonists in the treatment of neuropathic pain.
Jeffrey M Schkeryantz, Ann E Kingston, Michael P Johnson. J Med Chem 2007
35
50

JNJ16259685, a highly potent, selective and systemically active mGlu1 receptor antagonist.
Hilde Lavreysen, Ria Wouters, François Bischoff, Sandrina Nóbrega Pereira, Xavier Langlois, Saskia Blokland, Marijke Somers, Lieve Dillen, Anne S J Lesage. Neuropharmacology 2004
115
50

Anticonvulsant effects of LY456236, a selective mGlu1 receptor antagonist.
Harlan E Shannon, Steven C Peters, Ann E Kingston. Neuropharmacology 2005
31
50

Deleterious GRM1 mutations in schizophrenia.
Mohammed Akli Ayoub, Dora Angelicheva, David Vile, David Chandler, Bharti Morar, Juleen A Cavanaugh, Peter M Visscher, Assen Jablensky, Kevin D G Pfleger, Luba Kalaydjieva. PLoS One 2012
42
50


Assessment of a glycine uptake inhibitor in animal models of effort-related choice behavior: implications for motivational dysfunctions.
Samantha E Yohn, Daniela Alberati, Merce Correa, John D Salamone. Psychopharmacology (Berl) 2017
4
25

Both nicotine reward and withdrawal are enhanced in a rodent model of diabetes.
Joseph A Pipkin, Bryan Cruz, Rodolfo J Flores, Cecilia A Hinojosa, Luis M Carcoba, Melissa Ibarra, Wendy Francis, Arbi Nazarian, Laura E O'Dell. Psychopharmacology (Berl) 2017
12
25


Social defeat disrupts reward learning and potentiates striatal nociceptin/orphanin FQ mRNA in rats.
Andre Der-Avakian, Manoranjan S D'Souza, David N Potter, Elena H Chartoff, William A Carlezon, Diego A Pizzagalli, Athina Markou. Psychopharmacology (Berl) 2017
34
25

Non-nicotinic neuropharmacological strategies for nicotine dependence: beyond bupropion.
John F Cryan, Fabrizio Gasparini, Gino van Heeke, Athina Markou. Drug Discov Today 2003
57
25

Alterations of consciousness and mystical-type experiences after acute LSD in humans.
Matthias E Liechti, Patrick C Dolder, Yasmin Schmid. Psychopharmacology (Berl) 2017
73
25

Don't stress about CRF: assessing the translational failures of CRF1antagonists.
Samantha R Spierling, Eric P Zorrilla. Psychopharmacology (Berl) 2017
73
25

From bench to bedside: mGluR2 positive allosteric modulators as medications to treat substance use disorders.
Jane B Acri, Alan J Cross, Phil Skolnick. Psychopharmacology (Berl) 2017
9
25

Nicotine withdrawal-induced inattention is absent in alpha7 nAChR knockout mice.
K K Higa, A Grim, M E Kamenski, J van Enkhuizen, X Zhou, K Li, J C Naviaux, L Wang, R K Naviaux, M A Geyer,[...]. Psychopharmacology (Berl) 2017
11
25

Dramatic decreases in brain reward function during nicotine withdrawal.
M P Epping-Jordan, S S Watkins, G F Koob, A Markou. Nature 1998
516
25

Enduring deficits in brain reward function after chronic social defeat in rats: susceptibility, resilience, and antidepressant response.
Andre Der-Avakian, Michelle S Mazei-Robison, James P Kesby, Eric J Nestler, Athina Markou. Biol Psychiatry 2014
89
25

A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment.
Jose M Palacios, Angel Pazos, Daniel Hoyer. Psychopharmacology (Berl) 2017
52
25


Endogenous opioid system: a promising target for future smoking cessation medications.
Haval Norman, Manoranjan S D'Souza. Psychopharmacology (Berl) 2017
12
25

Metabotropic glutamate receptor 5 as a potential target for smoking cessation.
Cristiano Chiamulera, Claudio Marcello Marzo, David J K Balfour. Psychopharmacology (Berl) 2017
7
25


'Waiting impulsivity' in isolation-reared and socially-reared rats: effects of amphetamine.
Yia-Ping Liu, Lawrence S Wilkinson, Trevor W Robbins. Psychopharmacology (Berl) 2017
15
25

Association between nicotine withdrawal and reward responsiveness in humans and rats.
Michele L Pergadia, Andre Der-Avakian, Manoranjan S D'Souza, Pamela A F Madden, Andrew C Heath, Saul Shiffman, Athina Markou, Diego A Pizzagalli. JAMA Psychiatry 2014
56
25

Toll-like receptor signaling and stages of addiction.
Fulton T Crews, T Jordan Walter, Leon G Coleman, Ryan P Vetreno. Psychopharmacology (Berl) 2017
75
25

Neuropeptide systems and new treatments for nicotine addiction.
Adriaan W Bruijnzeel. Psychopharmacology (Berl) 2017
19
25

The ups and downs of addiction: role of metabotropic glutamate receptors.
Paul J Kenny, Athina Markou. Trends Pharmacol Sci 2004
175
25


A comparison of psychotic symptoms in subjects with methamphetamine versus cocaine dependence.
Peter D Alexander, Kristina M Gicas, Taylor S Willi, Clara N Kim, Veronika Boyeva, Ric M Procyshyn, Geoff N Smith, Allen E Thornton, William J Panenka, Andrea A Jones,[...]. Psychopharmacology (Berl) 2017
12
25

Assessing antidepressant activity in rodents: recent developments and future needs.
John F Cryan, Athina Markou, Irwin Lucki. Trends Pharmacol Sci 2002
25

KK-92A, a novel GABAB receptor positive allosteric modulator, attenuates nicotine self-administration and cue-induced nicotine seeking in rats.
Xia Li, Emmanuel Sturchler, Katarzyna Kaczanowska, Michael Cameron, M G Finn, Patrick Griffin, Patricia McDonald, Athina Markou. Psychopharmacology (Berl) 2017
9
25

Blunted 5-HT1A receptor-mediated responses and antidepressant-like behavior in mice lacking the GABAB1a but not GABAB1b subunit isoforms.
Laura H Jacobson, Daniel Hoyer, Dominique Fehlmann, Bernhard Bettler, Klemens Kaupmann, John F Cryan. Psychopharmacology (Berl) 2017
7
25

Bidirectional regulation over the development and expression of loss of control over cocaine intake by the anterior insula.
Jean-Yves Rotge, Paul J Cocker, Marie-Laure Daniel, Aude Belin-Rauscent, Barry J Everitt, David Belin. Psychopharmacology (Berl) 2017
18
25


Stress, anxiety and depression: toward new treatment strategies.
Athina Markou, John F Cryan. Neuropharmacology 2012
21
25

In Memory of Athina Markou (1961-2016): Obituary.
T W Robbins. Psychopharmacology (Berl) 2017
1
100

Perseveration in a spatial-discrimination serial reversal learning task is differentially affected by MAO-A and MAO-B inhibition and associated with reduced anxiety and peripheral serotonin levels.
Peter Zhukovsky, Johan Alsiö, Bianca Jupp, Jing Xia, Chiara Giuliano, Lucy Jenner, Jessica Griffiths, Errin Riley, Sajeed Ali, Angela C Roberts,[...]. Psychopharmacology (Berl) 2017
9
25

Modelling depression in animals: at the interface of reward and stress pathways.
D A Slattery, J F Cryan. Psychopharmacology (Berl) 2017
51
25

Evaluation of a novel PDE10A PET radioligand, [(11) C]T-773, in nonhuman primates: brain and whole body PET and brain autoradiography.
Akihiro Takano, Vladimir Stepanov, Balázs Gulyás, Ryuji Nakao, Nahid Amini, Shotaro Miura, Haruhide Kimura, Takahiko Taniguchi, Christer Halldin. Synapse 2015
13
25



Anhedonia to music and mu-opioids: Evidence from the administration of naltrexone.
Adiel Mallik, Mona Lisa Chanda, Daniel J Levitin. Sci Rep 2017
33
25

Identification of the allosteric P2X7 receptor antagonist [11C]SMW139 as a PET tracer of microglial activation.
Bieneke Janssen, Danielle J Vugts, Shane M Wilkinson, Dieter Ory, Sylvie Chalon, Jeroen J M Hoozemans, Robert C Schuit, Wissam Beaino, Esther J M Kooijman, Johan van den Hoek,[...]. Sci Rep 2018
28
25

Evaluation of 11C-BU99008, a PET ligand for the imidazoline2 binding sites in rhesus brain.
Christine A Parker, Nabeel Nabulsi, Daniel Holden, Shu-fei Lin, Tara Cass, David Labaree, Steven Kealey, Antony D Gee, Stephen M Husbands, Darren Quelch,[...]. J Nucl Med 2014
27
25

Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.
J Song, D Hanniford, C Doucette, E Graham, M F Poole, A Ting, B Sherf, J Harrington, K Brunden, A Stricker-Krongrad. Assay Drug Dev Technol 2005
18
25


Evaluation of the sensitivity of the novel α4β2* nicotinic acetylcholine receptor PET radioligand 18F-(-)-NCFHEB to increases in synaptic acetylcholine levels in rhesus monkeys.
Jean-Dominique Gallezot, Irina Esterlis, Frederic Bois, Ming-Qiang Zheng, Shu-Fei Lin, Tracy Kloczynski, John H Krystal, Yiyun Huang, Osama Sabri, Richard E Carson,[...]. Synapse 2014
15
25

Decreased density of I2-imidazoline receptors in the postmortem brain of heroin addicts.
M Sastre, P Ventayol, J A García-Sevilla. Neuroreport 1996
38
25

In Vivo Comparison of Tau Radioligands 18F-THK-5351 and 18F-THK-5317.
Tobey J Betthauser, Patrick J Lao, Dhanabalan Murali, Todd E Barnhart, Shozo Furumoto, Nobuyuki Okamura, Charles K Stone, Sterling C Johnson, Bradley T Christian. J Nucl Med 2017
31
25

Consensus nomenclature for in vivo imaging of reversibly binding radioligands.
Robert B Innis, Vincent J Cunningham, Jacques Delforge, Masahiro Fujita, Albert Gjedde, Roger N Gunn, James Holden, Sylvain Houle, Sung-Cheng Huang, Masanori Ichise,[...]. J Cereb Blood Flow Metab 2007
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.